Healthcare Services

Global Peptic Ulcer Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Peptic Ulcer Market Over The Period 2026–2030?

The peptic ulcer market size has shown steady expansion in recent years. It is anticipated to increase from $4.22 billion in 2025 to $4.35 billion in 2026, reflecting a compound annual growth rate (CAGR) of 3.3%. The historical period’s growth can be attributed to several factors including the high prevalence of h. pylori infections, insufficient awareness of peptic ulcer complications, the widespread use of NSAIDs, traditional symptomatic treatments, and inadequate early diagnosis.

The peptic ulcer market size is anticipated to experience consistent expansion over the upcoming years. This market is projected to reach $5.16 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.3%. Several factors will drive this growth during the forecast period, including the increased use of proton pump inhibitors and antibiotics, the proliferation of treatment facilities such as hospitals and private clinics, greater understanding of preventive care, breakthroughs in non-invasive diagnostic methods, and the expansion of e-commerce and retail pharmacy distribution channels. Key trends anticipated within this period involve the increasing integration of AI-based diagnostic tools, the development of personalized ulcer treatments leveraging genomics, the application of cloud and big data technologies for comprehensive patient monitoring, the incorporation of IoT devices for remote symptom surveillance, and advancements in the manufacturing processes for ulcer therapeutics.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13221&type=smp

What Underlying Factors Are Accelerating The Growth Of The Peptic Ulcer Market?

The expansion of the peptic ulcer market is anticipated due to the increasing incidence of obesity. This health condition involves an excessive build-up of body fat, often indicated by a body mass index (BMI) of 30 or higher. Factors like genetics, surroundings, and lifestyle choices such as inadequate diet and insufficient physical activity can cause obesity. It promotes the excessive production of stomach acid, compromises the stomach’s protective lining, and fosters the formation of peptic ulcers. Furthermore, surplus body weight appears to encourage gastrointestinal inflammation, which can also result in peptic ulcers. For example, the World Health Organization, an international intergovernmental organization headquartered in Switzerland, stated in May 2025 that 35 million children under the age of 5 were overweight in 2024. Consequently, the rising occurrence of obesity is fueling the growth of the peptic ulcer market.

How Is The Peptic Ulcer Market Divided Into Its Major Segments?

The peptic ulcer market covered in this report is segmented –

1) By Disease Indication: Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)

2) By Drug Type: Proton Pump Inhibitors (PPI), H2 Antagonists, Antibiotics, Other Drugs

3) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Store, Retail Pharmacies, E-Commerce

Subsegments:

1) By Gastritis: Acute Gastritis, Chronic Gastritis

2) By Gastric Ulcer: Acute Gastric Ulcer, Chronic Gastric Ulcer

3) By Duodenal Ulcer: Acute Duodenal Ulcer, Chronic Duodenal Ulcer

4) By Gastroesophageal Reflux Disease (GERD): Non-Erosive GERD, Erosive GERD

Which Upcoming Trends Are Expected To Influence The Peptic Ulcer Market?

Major companies operating within the peptic ulcer market are focused on creating novel solutions, including combination therapy drug kits, to meet the growing need for effective H. pylori eradication and ulcer management. Combination therapy kits incorporate multiple active ingredients into a unified regimen, thereby improving treatment adherence and offering a more targeted approach compared to traditional single-drug therapies. For instance, in April 2023, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical formulations and APIs company, launched Combikit, an advanced three-drug formulation. This Combikit comprises amoxicillin, clarithromycin, and esomeprazole, designed to simultaneously tackle bacterial elimination, acid suppression, and ulcer healing. It has received approval from the Central Drugs Standard Control Organisation (CDSCO) for treating duodenal ulcers linked to Helicobacter pylori (H. pylori) and for eradicating H. pylori in patients experiencing active or healed peptic ulcers. By integrating complementary mechanisms of action, the kit boosts treatment effectiveness, decreases the chances of ulcer recurrence, and improves patient cooperation, particularly in regions with high H. pylori prevalence.

Who Are The Prominent Organizations Shaping The Peptic Ulcer Market?

Major companies operating in the peptic ulcer market are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.

Read the full peptic ulcer market report here:

https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

Which Region Is Projected To Dominate The Peptic Ulcer Market During The Forecast Period?

North America was the largest region in the peptic ulcer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Peptic Ulcer Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13221&type=smp

Browse Through More Reports Similar to the Global Peptic Ulcer Market 2026, By The Business Research Company

Robotic Prosthetics Global Market Report

https://www.thebusinessresearchcompany.com/report/robotic-prosthetics-global-market-report

Orthopedic Prosthetics Global Market Report

https://www.thebusinessresearchcompany.com/report/orthopedic-prosthetics-global-market-report

Prosthetics And Orthotics Global Market Report

https://www.thebusinessresearchcompany.com/report/prosthetics-and-orthotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795